EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Microfluidic TFF Device for Biopharmaceutical Process Development: Scale‐Down Verification of Ultrafiltration and Diafiltration Modes for Monoclonal Antibodies

Nusrat Jahan iD, Nicolas Szita iD, Spyridon Konstantinidis iD, Marco P C Marques iD

Biotechnology and Bioengineering · 04.11.2026

DOI: 10.1002/bit.70437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 04.11.2026. Verfasst von Nusrat Jahan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Engineering, University College London, London, UK. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tangential flow filtration (TFF) is an essential operation in downstream bioprocessing, yet conventional scale‐down models require large material volumes and often fail to capture scale‐relevant hydrodynamics. A microfluidic TFF (µTFF) platform was developed that preserves wall shear rate and transmembrane pressure, enabling low‐volume investigation of UF/DF processes. Through iterative design of channel geometry and membrane selection, the final device achieved stable operation, high recovery, and a reduced runtime of 2.33 h from feed volumes as low as 10 mL for UF and 1 mL for DF. When operated at matched shear, the µTFF platform captured key bench‐scale filtration characteristics, including filtration time, TMP behavior, permeate‐flux profiles, and yields above 88% with negligible permeate loss. The device also resolved membrane‐dependent behavior across PES and RC chemistries, showing consistent cross‐scale trends for PES membranes while highlighting the influence of membrane‐specific variability on RC membrane performance and cross‐scale comparability. Validated with BSA and subsequently with monoclonal antibodies, the µTFF system demonstrated reproducible buffer exchange, maintained protein integrity, and replicated key transport phenomena. Its low working volumes, rapid turnaround, and ability to maintain scale‐relevant hydrodynamics position the µTFF platform as a high‐throughput screening tool for TFF process optimization, supporting faster development cycles and evaluation of purification strategies.

Schlagwörter

Stichwörter der Autor:innen

bioprocess developmenthigh‐throughput screeningmicrofluidicsmodular TFF devicemonoclonal antibodiesshear‐based scale‐down

Autor:innen und Institutionen

  • Department of Biochemical Engineering, University College London, London, UK.
  • Process Research and Development, MRL, Merck & Co., Inc, West Point, Pennsylvania, USA.

ORCID-Profile: Nusrat Jahan, Nicolas Szita, Spyridon Konstantinidis, Marco P C Marques

Förderung

  • Engineering and Physical Sciences Research Council

Zitieren

APA

Jahan, N., Szita, N., Konstantinidis, S., & Marques, M. P. C. (2026). A Microfluidic TFF Device for Biopharmaceutical Process Development: Scale‐Down Verification of Ultrafiltration and Diafiltration Modes for Monoclonal Antibodies. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70437

Vancouver

Jahan N, Szita N, Konstantinidis S, Marques MPC. A Microfluidic TFF Device for Biopharmaceutical Process Development: Scale‐Down Verification of Ultrafiltration and Diafiltration Modes for Monoclonal Antibodies. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70437

BibTeX
@article{Jahan2026,
  author = {Jahan, Nusrat and Szita, Nicolas and Konstantinidis, Spyridon and Marques, Marco P C},
  title = {A Microfluidic TFF Device for Biopharmaceutical Process Development: Scale‐Down Verification of Ultrafiltration and Diafiltration Modes for Monoclonal Antibodies},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70437}
}
Kostenlos starten →